News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,247 Results
Type
Article (14174)
Company Profile (282)
Press Release (251791)
Section
Business (79497)
Career Advice (153)
Deals (13224)
Drug Delivery (35)
Drug Development (50443)
Employer Resources (31)
FDA (5712)
Job Trends (5127)
News (144380)
Policy (10031)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (910)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21634)
ALS (60)
Alzheimer's disease (822)
Antibody-drug conjugate (ADC) (84)
Approvals (5724)
Artificial intelligence (106)
Autoimmune disease (10)
Automation (5)
Bankruptcy (104)
Best Places to Work (4560)
BIOSECURE Act (5)
Biosimilars (38)
Biotechnology (232)
Bladder cancer (43)
Brain cancer (19)
Breast cancer (137)
Cancer (1261)
Cardiovascular disease (100)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (303)
Cervical cancer (6)
Clinical research (40828)
Collaboration (492)
Compensation (216)
Complete response letters (13)
COVID-19 (1033)
CRISPR (36)
C-suite (137)
Cystic fibrosis (76)
Data (1301)
Denatured (11)
Depression (28)
Diabetes (122)
Diagnostics (1290)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (76)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (77)
Earnings (29569)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48062)
Executive appointments (396)
FDA (6317)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (459)
Gene editing (87)
Generative AI (9)
Gene therapy (225)
GLP-1 (351)
Government (1074)
Grass and pollen (2)
Guidances (18)
Healthcare (6587)
Huntington's disease (21)
IgA nephropathy (20)
Immunology and inflammation (78)
Indications (18)
Infectious disease (1092)
Inflammatory bowel disease (109)
Inflation Reduction Act (8)
Influenza (17)
Intellectual property (55)
Interviews (17)
IPO (7261)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (199)
Leadership (2)
Legal (1386)
Liver cancer (30)
Lung cancer (178)
Lymphoma (81)
Machine learning (1)
Management (7)
Manufacturing (114)
MASH (46)
Medical device (2592)
Medtech (2593)
Mergers & acquisitions (6245)
Metabolic disorders (357)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (55)
Neuropsychiatric disorders (23)
Neuroscience (1182)
NextGen: Class of 2025 (2016)
Non-profit (852)
Northern California (1505)
Now hiring (21)
Obesity (183)
Opinion (100)
Ovarian cancer (58)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (102)
Partnered (6)
Patents (106)
Patient recruitment (64)
Peanut (35)
People (25475)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14414)
Phase II (18995)
Phase III (12008)
Pipeline (641)
Podcasts (45)
Policy (34)
Postmarket research (853)
Preclinical (6049)
Press Release (30)
Prostate cancer (51)
Psychedelics (35)
Radiopharmaceuticals (211)
Rare diseases (268)
Real estate (1414)
Recruiting (12)
Regulatory (8541)
Reports (15)
Research institute (936)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (90)
Series B (58)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1339)
Special edition (11)
Spinal muscular atrophy (116)
Sponsored (11)
Startups (1972)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (33)
United States (11850)
Vaccines (204)
Venture capitalists (28)
Webinars (7)
Weight loss (104)
Women's health (15)
Worklife (2)
Date
Today (102)
Last 7 days (365)
Last 30 days (1724)
Last 365 days (20105)
2025 (4388)
2024 (20556)
2023 (22416)
2022 (26825)
2021 (27807)
2020 (23360)
2019 (16229)
2018 (11741)
2017 (13747)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7487)
2012 (7532)
2011 (7614)
2010 (7429)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (51)
Arkansas (5)
Asia (17197)
Australia (2914)
California (3442)
Canada (1037)
China (312)
Colorado (130)
Connecticut (141)
Delaware (86)
Europe (36985)
Florida (400)
Georgia (105)
Idaho (16)
Illinois (208)
India (7)
Indiana (85)
Iowa (1)
Japan (66)
Kansas (58)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (439)
Massachusetts (2716)
Michigan (69)
Minnesota (133)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (861)
New Mexico (12)
New York (943)
North Carolina (512)
North Dakota (4)
Northern California (1505)
Ohio (107)
Oklahoma (9)
Oregon (21)
Pennsylvania (654)
Puerto Rico (3)
Rhode Island (14)
South America (208)
South Carolina (4)
Southern California (1339)
Tennessee (25)
Texas (387)
Utah (48)
Virginia (67)
Washington D.C. (28)
Washington State (315)
Wisconsin (13)
266,247 Results for "adagio therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adagio Medical Provides Clinical and Business Updates
March 18, 2025
·
5 min read
Press Releases
Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation
March 3, 2025
·
5 min read
Press Releases
Adagio Medical to Participate at the TD Cowen’s 45th Annual Health Care Conference
February 18, 2025
·
1 min read
Press Releases
Adagio Medical Reports Third Quarter 2024 Results
November 14, 2024
·
6 min read
Biotech Beach
Adagio Medical Announces First European Commercial Procedures and Commencement of U.S. FDA Pivotal IDE for Ventricular Tachycardia Cryoablation System
Adagio Medical, Inc. (“Adagio Medical”, “Adagio” or the “Company”) today announced the completion of the first commercial procedures using its recently CE-Marked VT Cryoablation System and the U.S. Food and Drug Administration (“FDA”) approval of the FULCRUM-VT Pivotal IDE study of the VT Cryoablation System.
May 16, 2024
·
12 min read
Press Releases
Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director
December 16, 2024
·
5 min read
Press Releases
Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias
October 7, 2024
·
1 min read
Biotech Beach
Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market
Adagio Medical, Inc. announced the first ultra-low temperature cryoablation (ULTC) procedure performed using the Adagio vCLAS™ catheter system in the United States as part of the FULCRUM-VT (Feasibility of Ultra-Low Temperature Cryoablation for Recurring Monomorphic Ventricular Tachycardia) clinical trial, NCT # NCT05675865.
September 13, 2023
·
4 min read
Policy
Adagio Medical Announces Completion of Enrollment in Cryocure-VT Trial, Maps the Pathway to CE-Mark of vCLAS™ VT Ablation Catheter
Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation and ventricular tachycardia, announced the completion of enrollment in its Cryocure-VT trial of ultra-low temperature cryoablation for the treatment of monomorphic ventricular tachycardias.
May 3, 2023
·
3 min read
Business
Movers & Shakers: Adagio, Harpoon, Aravive, Nitrase and More
Adagio, Aravive, PolyPid, Harpoon, Durect, Nitrase, Kallyope, TScan and many more made major leadership decisions this week.
July 7, 2022
·
4 min read
·
Alex Keown
1 of 26,625
Next
